The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021: Featured Updates to the NCCN Guidelines
Abstract
Over the past few years, the NCCN Guidelines for Melanoma: Cutaneous have been expanded to include pathways for treatment of microscopic satellitosis (added in v2.2020), and the following Principles sections: Molecular Testing (added in v2.2019), Systemic Therapy Considerations (added in v2.2020), and Brain Metastases Management (added in v3.2020). The v1.2021 update included additional modifications of these sections and notable revisions to Principles of: Pathology, Surgical Margins for Wide Excision of Primary Melanoma, Sentinel Lymph Node Biopsy, Completion/Therapeutic Lymph Node Dissection, and Radiation Therapy. These NCCN Guidelines Insights discuss the important changes to pathology and surgery recommendations, as well as additions to systemic therapy options for patients with advanced disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2017) · Springer eBooks · doi:10.1007/978-3-319-40618-3 · Cited by 17,242
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
Larkin, J., Chiarion-Sileni, V., Gonzalez, R., Grob, J. J., Cowey, C. L., Lao, C. D., Schadendorf, D., Dummer, R., Smylie, M., Rutkowski, P., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504030 · Cited by 8,157
Self-citationPembrolizumab versus Ipilimumab in Advanced Melanoma
Robert, C., Schachter, J., Long, G. V., Arance, A., Grob, J. J., Mortier, L., Daud, A., Carlino, M. S., McNeil, C., Lotem, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1503093 · Cited by 5,887
Nivolumab in Previously Untreated Melanoma without BRAF Mutation
Robert, C., Long, G. V., Brady, B., Dutriaux, C., Maio, M., Mortier, L., Hassel, J. C., Rutkowski, P., McNeil, C., Kalinka-Warzocha, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1412082 · Cited by 5,519
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
Wolchok, J. D., Chiarion-Sileni, V., Gonzalez, R., Rutkowski, P., Grob, J.-J., Cowey, C. L., Lao, C. D., Wagstaff, J., Schadendorf, D., Ferrucci, P. F., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1709684 · Cited by 5,357
Self-citationFinal Version of 2009 AJCC Melanoma Staging and Classification
Balch, C. M., Gershenwald, J. E., Soong, S.-J., Thompson, J. F., Atkins, M. B., Byrd, D. R., Buzaid, A. C., Cochran, A. J., Coit, D. G., Ding, S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.4799 · Cited by 4,602
Self-citationFive-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
Larkin, J., Chiarion-Sileni, V., Gonzalez, R., Grob, J.-J., Rutkowski, P., Lao, C. D., Cowey, C. L., Schadendorf, D., Wagstaff, J., Dummer, R., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1910836 · Cited by 3,723
Nivolumab and ipilimumab versus ipilimumab in untreated melanoma
Postow, M. A., Chesney, J., Pavlick, A. C., Robert, C., Grossmann, K., McDermott, D., Linette, G. P., Meyer, N., Giguere, J. K., Agarwala, S. S., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1414428 · Cited by 2,781
Self-citationImproved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
Robert, C., Karaszewska, B., Schachter, J., Rutkowski, P., Mackiewicz, A., Stroiakovski, D., Lichinitser, M., Dummer, R., Grange, F., Mortier, L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1412690 · Cited by 2,701
Weber, J. S., D'Angelo, S. P., Minor, D., Hodi, F. S., Gutzmer, R., Neyns, B., Hoeller, C., Khushalani, N. I., Miller, W. H., Lao, C. D., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)70076-8 · Cited by 2,676
Self-citationBalch, C. M., Soong, S.-J., Gershenwald, J. E., Thompson, J. F., Reintgen, D. S., Cascinelli, N., Urist, M., McMasters, K. M., Ross, M. I., Kirkwood, J. M., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.16.3622 · Cited by 2,388
Self-citationGershenwald, J. E., Scolyer, R. A., Hess, K. R., Sondak, V. K., Long, G. V., Ross, M. I., Lazar, A. J., Faries, M. B., Kirkwood, J. M., McArthur, G. A., et al. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21409 · Cited by 2,283
Self-citationAdjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma
Weber, J., Mandala, M., Del Vecchio, M., Gogas, H. J., Arance, A. M., Cowey, C. L., Dalle, S., Schenker, M., Chiarion-Sileni, V., Marquez-Rodas, I., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1709030 · Cited by 2,246
Combined Vemurafenib and Cobimetinib in BRAF -Mutated Melanoma
Larkin, J., Ascierto, P. A., Dréno, B., Atkinson, V., Liszkay, G., Maio, M., Mandalà, M., Demidov, L., Stroyakovskiy, D., Thomas, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408868 · Cited by 2,068
Adjuvant pembrolizumab versus placebo in resected stage III melanoma
Eggermont, A. M. M., Blank, C. U., Mandala, M., Long, G. V., Atkinson, V., Dalle, S., Haydon, A., Lichinitser, M., Khattak, A., Carlino, M. S., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1802357 · Cited by 1,906
Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma
Long, G. V., Hauschild, A., Santinami, M., Atkinson, V., Mandalà, M., Chiarion-Sileni, V., Larkin, J., Nyakas, M., Dutriaux, C., Haydon, A., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1708539 · Cited by 1,490
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
Faries, M. B., Thompson, J. F., Cochran, A. J., Andtbacka, R. H., Mozzillo, N., Zager, J. S., Jahkola, T., Bowles, T. L., Testori, A., Beitsch, P. D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1613210 · Cited by 1,414
Self-citationHodi, F. S., Chiarion-Sileni, V., Gonzalez, R., Grob, J.-J., Rutkowski, P., Cowey, C. L., Lao, C. D., Schadendorf, D., Wagstaff, J., Dummer, R., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30700-9 · Cited by 1,399
Long, G. V., Stroyakovskiy, D., Gogas, H., Levchenko, E., de Braud, F., Larkin, J., Garbe, C., Jouary, T., Hauschild, A., Grob, J.-J., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60898-4 · Cited by 1,399
Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy
Eggermont, A. M. M., Chiarion-Sileni, V., Grob, J.-J., Dummer, R., Wolchok, J. D., Schmidt, H., Hamid, O., Robert, C., Ascierto, P. A., Richards, J. M., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1611299 · Cited by 1,318
Schachter, J., Ribas, A., Long, G. V., Arance, A., Grob, J.-J., Mortier, L., Daud, A., Carlino, M. S., McNeil, C., Lotem, M., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31601-x · Cited by 1,225
Robert, C., Ribas, A., Schachter, J., Arance, A., Grob, J.-J., Mortier, L., Daud, A., Carlino, M. S., McNeil, C. M., Lotem, M., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30388-2 · Cited by 1,159
Dummer, R., Ascierto, P. A., Gogas, H. J., Arance, A., Mandala, M., Liszkay, G., Garbe, C., Schadendorf, D., Krajsova, I., Gutzmer, R., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30142-6 · Cited by 1,037
Ascierto, P. A., McArthur, G. A., Dréno, B., Atkinson, V., Liszkay, G., Di Giacomo, A. M., Mandalà, M., Demidov, L., Stroyakovskiy, D., Thomas, L., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30122-x · Cited by 1,022
Hodi, F. S., Chesney, J., Pavlick, A. C., Robert, C., Grossmann, K. F., McDermott, D. F., Linette, G. P., Meyer, N., Giguere, J. K., Agarwala, S. S., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30366-7 · Cited by 968
Self-citationAzimi, F., Scolyer, R. A., Rumcheva, P., Moncrieff, M., Murali, R., McCarthy, S. W., Saw, R. P., & Thompson, J. F. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.8539 · Cited by 856
Self-citationGuidelines of care for the management of primary cutaneous melanoma
Swetter, S. M., Tsao, H., Bichakjian, C. K., Curiel-Lewandrowski, C., Elder, D. E., Gershenwald, J. E., Guild, V., Grant-Kels, J. M., Halpern, A. C., Johnson, T. M., et al. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.08.055 · Cited by 727
Self-citationLong, G. V., Flaherty, K. T., Stroyakovskiy, D., Gogas, H., Levchenko, E., de Braud, F., Larkin, J., Garbe, C., Jouary, T., Hauschild, A., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx176 · Cited by 671
Dummer, R., Ascierto, P. A., Gogas, H. J., Arance, A., Mandala, M., Liszkay, G., Garbe, C., Schadendorf, D., Krajsova, I., Gutzmer, R., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30497-2 · Cited by 588
BALCH, C. M., MURAD, T. M., SOONG, S.-J., INGALLS, A. L., HALPERN, N. B., & MADDOX, W. A. (1978) · Annals of Surgery · doi:10.1097/00000658-197812000-00004 · Cited by 576
Thin Stage I Primary Cutaneous Malignant Melanoma
Veronesi, U., Cascinelli, N., Adamus, J., Balch, C., Bandiera, D., Barchuk, A., Bufalino, R., Craig, P., De Marsillac, J., Durand, J. C., et al. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805053181804 · Cited by 563
WHO Classification of Tumours: An Overview
Yakin, M., & Logan, R. (2025) · Pathological Basis of Oral and Maxillofacial Diseases · doi:10.1002/9781119989233.ch26 · Cited by 555
Balch, C. M., Urist, M. M., Karakousis, C. P., Smith, T. J., Temple, W. J., Drzewiecki, K., Jewell, W. R., Bartolucci, A. A., Mihm, M. C., Barnhill, R., et al. (1993) · Annals of Surgery · doi:10.1097/00000658-199309000-00005 · Cited by 525
Larkin, J., Minor, D., D'Angelo, S., Neyns, B., Smylie, M., Miller, W. H., Gutzmer, R., Linette, G., Chmielowski, B., Lao, C. D., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2016.71.8023 · Cited by 516
Self-citationThe Molecular Pathology of Melanoma: An Integrated Taxonomy of Melanocytic Neoplasia
Bastian, B. C. (2014) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012513-104658 · Cited by 513
Excision Margins in High-Risk Malignant Melanoma
Thomas, J. M., Newton‐Bishop, J., A’Hern, R., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa030681 · Cited by 504
Nivolumab in Previously Untreated Melanoma without BRAF Mutation
Robert, C., Long, G. V., Brady, B., et al. (2015) · Kölner Universitäts PublikationsServer (Universität zu Köln) · Cited by 495
Balch, C. M., Gershenwald, J. E., Soong, S.-J., Thompson, J. F., Ding, S., Byrd, D. R., Cascinelli, N., Cochran, A. J., Coit, D. G., Eggermont, A. M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.1627 · Cited by 410
Self-citationLebbé, C., Meyer, N., Mortier, L., Marquez-Rodas, I., Robert, C., Rutkowski, P., Menzies, A. M., Eigentler, T., Ascierto, P. A., Smylie, M., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.01998 · Cited by 408
Balch, C. M., Soong, S.-J., Smith, T., Ross, M. I., Urist, M. M., Karakousis, C. P., Temple, W. J., Mihm, M. C., Barnhill, R. L., Jewell, W. R., et al. (2001) · Annals of Surgical Oncology · doi:10.1007/s10434-001-0101-x · Cited by 406
Self-citationSondak, V. K., Taylor, J. M. G., Sabel, M. S., Wang, Y., Lowe, L., Grover, A. C., Chang, A. E., Yahanda, A. M., Moon, J., & Johnson, T. M. (2004) · Annals of Surgical Oncology · doi:10.1245/aso.2004.03.044 · Cited by 328
Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma
Ascierto, P. A., Ferrucci, P. F., Fisher, R., Del Vecchio, M., Atkinson, V., Schmidt, H., Schachter, J., Queirolo, P., Long, G. V., Di Giacomo, A. M., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0448-9 · Cited by 324
Ribas, A., Gonzalez, R., Pavlick, A., Hamid, O., Gajewski, T. F., Daud, A., Flaherty, L., Logan, T., Chmielowski, B., Lewis, K., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70301-8 · Cited by 299
Self-citationTaylor, R. C., Patel, A., Panageas, K. S., Busam, K. J., & Brady, M. S. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.9755 · Cited by 297
Kuchelmeister, C., Schaumburg-Lever, G., & Garbe, C. (2000) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2000.03651.x · Cited by 260
Leiter, U., Stadler, R., Mauch, C., Hohenberger, W., Brockmeyer, N. H., Berking, C., Sunderkötter, C. H., Kaatz, M., Schatton, K., Lehmann, P. M., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.02306 · Cited by 255
Long, G. V., Atkinson, V., Cebon, J. S., Jameson, M. B., Fitzharris, B. M., McNeil, C. M., Hill, A. G., Ribas, A., Atkins, M. B., Thompson, J. A., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30428-x · Cited by 245
Self-citationGillgren, P., Drzewiecki, K. T., Niin, M., Gullestad, H. P., Hellborg, H., Månsson-Brahme, E., Ingvar, C., & Ringborg, U. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61546-8 · Cited by 228
Long, G. V., Eroglu, Z., Infante, J., Patel, S., Daud, A., Johnson, D. B., Gonzalez, R., Kefford, R., Hamid, O., Schuchter, L., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.1025 · Cited by 221
Self-citationCutaneous head and neck melanoma treated with Mohs micrographic surgery
Bricca, G. M., Brodland, D. G., Ren, D., & Zitelli, J. A. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.08.038 · Cited by 216
Johnson, D. B., Flaherty, K. T., Weber, J. S., Infante, J. R., Kim, K. B., Kefford, R. F., Hamid, O., Schuchter, L., Cebon, J., Sharfman, W. H., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.3535 · Cited by 216
Self-citationMaio, M., Lewis, K., Demidov, L., Mandalà, M., Bondarenko, I., Ascierto, P. A., Herbert, C., Mackiewicz, A., Rutkowski, P., Guminski, A., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30106-2 · Cited by 216
Self-citationCutaneous Desmoplastic Melanoma: Reappraisal of Morphologic Heterogeneity and Prognostic Factors
Busam, K. J., Mujumdar, U., Hummer, A. J., Nobrega, J., Hawkins, W. G., Coit, D. G., & Brady, M. S. (2004) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000141391.91677.a4 · Cited by 199
Ferrucci, P. F., Di Giacomo, A. M., Del Vecchio, M., Atkinson, V., Schmidt, H., Schachter, J., Queirolo, P., Long, G. V., Stephens, R., Svane, I. M., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001806 · Cited by 192
Balch, C. M., Thompson, J. F., Gershenwald, J. E., Soong, S.-J., Ding, S., McMasters, K. M., Coit, D. G., Eggermont, A. M. M., Gimotty, P. A., Johnson, T. M., et al. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-013-3464-x · Cited by 183
Self-citationAscierto, P. A., Dummer, R., Gogas, H. J., Flaherty, K. T., Arance, A., Mandala, M., Liszkay, G., Garbe, C., Schadendorf, D., Krajsova, I., et al. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2019.11.016 · Cited by 181
Gimotty, P. A., Van Belle, P., Elder, D. E., Murry, T., Montone, K. T., Xu, X., Hotz, S., Raines, S., Ming, M. E., Wahl, P., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.0735 · Cited by 175
Update on primary mucosal melanoma
Tacastacas, J. D., Bray, J., Cohen, Y. K., Arbesman, J., Kim, J., Koon, H. B., Honda, K., Cooper, K. D., & Gerstenblith, M. R. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2014.03.031 · Cited by 162
Etzkorn, J. R., Sobanko, J. F., Elenitsas, R., Newman, J. G., Goldbach, H. S., Shin, T. M., & Miller, C. J. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.01.007 · Cited by 154
Hayes, A. J., Maynard, L., Coombes, G., Newton‐Bishop, J., Timmons, M. J., Cook, M. G., Theaker, J. M., Bliss, J. M., & Thomas, J. M. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00482-9 · Cited by 151
Desmoplastic Melanoma: A Pathologically and Clinically Distinct Form of Cutaneous Melanoma
Hawkins, W. G., BUSAM, K. J., Ben‐Porat, L., Panageas, K. S., Coit, D. G., Gyorki, D. E., Linehan, D. C., & Brady, M. S. (2005) · Annals of Surgical Oncology · doi:10.1245/aso.2005.03.022 · Cited by 147
Nagore, E., Oliver, V., Estrada, R. B., Moreno-Picot, S., Insa, A., & Fortea, J. M. (2005) · Melanoma Research · doi:10.1097/00008390-200506000-00005 · Cited by 143
Prognostic factors in cutaneous desmoplastic melanoma: A study of 252 patients
Murali, R., Shaw, H. M., Lai, K., McCarthy, S. W., Quinn, M. J., Stretch, J. R., Thompson, J. F., & Scolyer, R. A. (2010) · Cancer · doi:10.1002/cncr.25148 · Cited by 129
Self-citationVascular Involvement in the Prognosis of Primary Cutaneous Melanoma
Kashani–Sabet, M., Sagebiel, R. W., Ferreira, C. M. M., Nosrati, M., & Miller, J. R. (2001) · Archives of Dermatology · doi:10.1001/archderm.137.9.1169 · Cited by 129
Leiter, U., Buettner, P. G., Eigentler, T., & Garbe, C. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.03.074 · Cited by 127
Prediction of Survival in Patients With Thin Melanoma: Results From a Multi-Institution Study
Maurichi, A., Miceli, R., Camerini, T., Mariani, L., Patuzzo, R., Ruggeri, R., Gallino, G., Tolomio, E., Tragni, G., Valeri, B., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.2340 · Cited by 127
The Prognostic Importance of Sentinel Lymph Node Biopsy in Thin Melanoma
Ranieri, J. M., Wagner, J. D., Wenck, S., Johnson, C. S., & Coleman, J. J. (2006) · Annals of Surgical Oncology · doi:10.1245/aso.2006.04.023 · Cited by 121
The importance of mitotic rate as a prognostic factor for localized cutaneous melanoma
Barnhill, R. L., Katzen, J., Spatz, A., Fine, J., & Berwick, M. (2005) · Journal of Cutaneous Pathology · doi:10.1111/j.0303-6987.2005.00310.x · Cited by 117
Storr, S. J., Safuan, S., Mitra, A., Elliott, F., Walker, C., Vasko, M. J., Ho, B. C. S., Cook, M. G., Mohammed, R. A., Patel, P. M., et al. (2011) · Modern Pathology · doi:10.1038/modpathol.2011.182 · Cited by 116
Predicting sentinel node status in AJCC stage I/II primary cutaneous melanoma
Kruper, L. L., Spitz, F. R., Czerniecki, B. J., Fraker, D. L., Blackwood‐Chirchir, A., Ming, M. E., Elder, D. E., Elenitsas, R., Guerry, D., & Gimotty, P. A. (2006) · Cancer · doi:10.1002/cncr.22295 · Cited by 115
Valentín‐Nogueras, S. M., Brodland, D. G., Zitelli, J. A., González‐Sepúlveda, L., & Nazario, C. M. (2016) · Dermatologic Surgery · doi:10.1097/dss.0000000000000725 · Cited by 115
Regression in primary cutaneous melanoma: etiopathogenesis and clinical significance
Aung, P. P., Nagarajan, P., & Prieto, V. G. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.8 · Cited by 110
Grossman, D., Okwundu, N., Bartlett, E. K., Marchetti, M. A., Othus, M. K. D., Coit, D. G., Hartman, R. I., Leachman, S. A., Berry, E., Korde, L. A., et al. (2020) · JAMA Dermatology · doi:10.1001/jamadermatol.2020.1729 · Cited by 110
Self-citationDréno, B., Ribas, A., Larkin, J., Ascierto, P. A., Hauschild, A., Thomas, L., Grob, J., Koralek, D. O., Rooney, I. A., Hsu, J. J., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx040 · Cited by 101
Biology of advanced uveal melanoma and next steps for clinical therapeutics
Luke, J. J., Triozzi, P. L., McKenna, K. C., Meir, E. G. V., Gershenwald, J. E., Bastian, B. C., Gutkind, J. S., Bowcock, A. M., STREICHER, H. Z., Patel, P. M., et al. (2014) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12304 · Cited by 95
Self-citationA diagnostic algorithm to distinguish desmoplastic from spindle cell melanoma
Weissinger, S. E., Keil, P., Silvers, D. N., Klaus, B. M., Mӧller, P., Horst, B. A. J., & Lennerz, J. K. (2013) · Modern Pathology · doi:10.1038/modpathol.2013.162 · Cited by 86
Hanson, J., Demer, A. M., Liszewski, W. J., Foman, N., & Maher, I. A. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2019.08.059 · Cited by 86
Association of Histologic Regression in Primary Melanoma With Sentinel Lymph Node Status
Ribero, S., Gualano, M. R., Osella‐Abate, S., Scaioli, G., Bert, F., Sanlorenzo, M., Balagna, E., Fierro, M. T., Macripò, G., Sapino, A., et al. (2015) · JAMA Dermatology · doi:10.1001/jamadermatol.2015.2235 · Cited by 73
Tejera‐Vaquerizo, A., Ribero, S., Puig, S., et al. (2019) · Cancer Medicine · doi:10.1002/cam4.2358 · Cited by 61
Marchetti, M. A., Coit, D. G., Dusza, S. W., Yu, A. M., McLean, L., Hu, Y., Nanda, J. K., Matsoukas, K., Mancebo, S. E., & Bartlett, E. K. (2020) · JAMA Dermatology · doi:10.1001/jamadermatol.2020.1731 · Cited by 60
Clinical and Dermoscopic Characteristics of Desmoplastic Melanomas
Jaimes, N., Chen, L. L., Dusza, S. W., Carrera, C., Puig, S., Thomas, L., Kelly, J. W., Dang, L., Zalaudek, I., Braun, R. P., et al. (2013) · JAMA Dermatology · doi:10.1001/jamadermatol.2013.2248 · Cited by 59
Ascierto, P. A., Long, G. V., Robert, C., Brady, B., Dutriaux, C., Di Giacomo, A. M., Mortier, L., Hassel, J. C., Rutkowski, P., McNeil, C., et al. (2019) · Kölner Universitäts PublikationsServer (Universität zu Köln) · Cited by 59
Eriksson, H., Frohm‐Nilsson, M., Järås, J., Kanter‐Lewensohn, L. R., Kjellman, P., Månsson‐Brahme, E., Vassilaki, I., & Hansson, J. (2014) · British Journal of Dermatology · doi:10.1111/bjd.13171 · Cited by 55
Sentinel Lymph Node Biopsy in Thin Cutaneous Melanoma: A Systematic Review and Meta-Analysis
Cordeiro, E., Gervais, M., Shah, P., Hong, N. L., & Wright, F. C. (2016) · Annals of Surgical Oncology · doi:10.1245/s10434-016-5137-z · Cited by 51
Lyth, J., Hansson, J., Ingvar, C., Månsson‐Brahme, E., Naredi, P. L. J., Stierner, U. K., Wagenius, G., Lindholm, C., & for the Swedish Melanoma Study Group (2012) · British Journal of Dermatology · doi:10.1111/bjd.12095 · Cited by 50
Carlino, M. S., Menzies, A. M., Atkinson, V. G., Cebon, J. S., Jameson, M. B., Fitzharris, B. M., McNeil, C. M., Hill, A. G., Ribas, A., Atkins, M. B., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-0177 · Cited by 48
Self-citationRisk Factors Predicting Positive Margins at Primary Wide Local Excision of Cutaneous Melanoma
Mangold, A. R., Skinner, R., Dueck, A. C., Sekulic, A., & Pockaj, B. A. (2016) · Dermatologic Surgery · doi:10.1097/dss.0000000000000702 · Cited by 38
Clinicopathologic Predictors of Survival in Patients with Desmoplastic Melanoma
Han, D., Han, G., Zhao, X., Rao, N. G., Messina, J. L., Marzban, S. S., Sarnaik, A. A., Cruse, C. W., Sondak, V. K., & Zager, J. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119716 · Cited by 37
Etzkorn, J. R., Sobanko, J. F., Shin, T. M., Elenitsas, R., Chu, E. Y., Gelfand, J. M., Margolis, D. J., Newman, J. G., Goldbach, H. S., & Miller, C. J. (2016) · Dermatologic Surgery · doi:10.1097/dss.0000000000000693 · Cited by 29
Egger, M. E., Stevenson, M. A., Bhutiani, N., Jordan, A. C., Scoggins, C. R., Philips, P., Martin, R. C. G., & McMasters, K. M. (2019) · Annals of Surgical Oncology · doi:10.1245/s10434-019-07690-4 · Cited by 28
Lentigo Maligna and Lentigo Maligna Melanoma: Contemporary Issues in Diagnosis and Management
Connolly, K. L., Nehal, K. S., & BUSAM, K. J. (2015) · Melanoma Management · doi:10.2217/mmt.15.3 · Cited by 25
Long, G., Eroglu, Z., Infante, J. R., Patel, S., Johnson, D., Gonzalez, R., Kefford, R., Hamid, O., Schuchter, L. M., Cebon, J., et al. (2018) · eScholarship (California Digital Library) · Cited by 25
Self-citationHunger, R. E., Angermeier, S., Jafari, S. M. S., et al. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.03.029 · Cited by 23
Treatments and associated outcomes of acral lentiginous melanoma: A review
Lobl, M. B., Santos, C., Clarey, D. D., Higgins, S., Silva‐Lopez, E., Sutton, A., & Wysong, A. S. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2019.11.021 · Cited by 13
Gene Expression Profile Testing for Thin Melanoma
Kovarik, C., Chu, E. Y., & Adamson, A. S. (2020) · JAMA Dermatology · doi:10.1001/jamadermatol.2020.0894 · Cited by 10
Cited by
Luke, J. J., Rutkowski, P., Queirolo, P., Del Vecchio, M., Mackiewicz, J., Chiarion-Sileni, V., de la Cruz Merino, L., Khattak, M. A., Schadendorf, D., Long, G. V., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00562-1 · Cited by 499
Chakravarty, D., Johnson, A., Sklar, J., Lindeman, N. I., Moore, K., Ganesan, S., Lovly, C. M., Perlmutter, J., Gray, S. W., Hwang, J., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.02767 · Cited by 266
Acral melanoma in skin of color: current insights and future directions: a narrative review
Nadelmann, E., Singh, A., Abbruzzese, M., Adeuyan, O., Kenchappa, D., Kovrizhkin, K., Lightman, M., Samouha, A., Tao, K., Yun, J., et al. (2025) · Cancers · doi:10.3390/cancers17030468 · Cited by 20
Basic elements of artificial intelligence tools in the diagnosis of cutaneous melanoma
Querzoli, G., Veronesi, G., Corti, B., Nottegar, A., & Dika, E. (2023) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2023050220 · Cited by 6
Metadata
- Authors
- Swetter, S. M., Thompson, J. A., Albertini, M. R., Barker, C. A., Baumgartner, J., Boland, G., Chmielowski, B., DiMaio, D., Durham, A., Fields, R. C., Fleming, M. D., Galan, A., Gastman, B., Grossmann, K., Guild, S., Holder, A., Johnson, D., Joseph, R. W., Karakousis, G., Kendra, K., Lange, J. R., Lanning, R., Margolin, K., Olszanski, A. J., Ott, P. A., Ross, M. I., Salama, A. K., Sharma, R., Skitzki, J., Sosman, J., Wuthrick, E., McMillian, N. R., & Engh, A. M.
- Venue
- Journal of the National Comprehensive Cancer Network
- Publisher
- Harborside Press, LLC
- Published
- 2021-04
- Volume
- 19
- Issue
- 4
- Pages
- 364-376
- ISSN
- 1540-1405 (ISSN-L)
- 1540-1413
- OpenAlex
- W3155147933
- Cited by
- 340
- References
- 95
- FWCI
- 20.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.